Ulinastatin, a Urinary Trypsin Inhibitor, for the Initial Treatment of Patients With Kawasaki Disease
- 1 December 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 124 (25) , 2822-2828
Abstract
Background—: Markedly activated neutrophils or higher plasma levels of neutrophil elastase are involved in the poor response to intravenous immunoglobulin (IVIG) and the formation of coronary artery lesions (CAL) in patients with acute Kawasaki disease. We hypothesized that ulinastatin (UTI), by both direct and indirect suppression of neutrophils, would reduce the occurrence of CAL. Methods and Results—: We retrospectively analyzed the clinical records of patients with Kawasaki disease between 1998 and 2009. Three hundred sixty-nine patients were treated with a combination of UTI, aspirin, and IVIG as an initial treatment (UTI group), and 1178 were treated with a conventional initial treatment, and IVIG with aspirin (control group). The baseline characteristics did not demonstrate notable differences between the two groups. The occurrence of CAL was significantly lower in the UTI group than in the control group (3% versus 7%; crude odds ratio [OR], 0.46; 95% confidence interval [CI], 0.25–0.86; P =0.01). The OR adjusted for sex, Gunma score (the predictive score for IVIG unresponsiveness), and dosage of initial IVIG (1 or 2 g/kg) was 0.32 (95% CI, 0.17–0.60; P P P <0.001). Conclusions—: UTI was associated with fewer patients requiring additional rescue treatment and reduction of CAL in this retrospective study.Keywords
This publication has 40 references indexed in Scilit:
- Atipical kawasaki disease with coronary aneurysm in infantItalian Journal of Pediatrics, 2011
- Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki diseaseJournal of Human Genetics, 2010
- Resistance to Intravenous Immunoglobulin in Children with Kawasaki DiseaseThe Journal of Pediatrics, 2008
- Pulse methylprednisolone with gammaglobulin as an initial treatment for acute Kawasaki diseaseEuropean Journal of Pediatrics, 2008
- The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinasesArchives of Disease in Childhood, 2006
- A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: Clinical course and coronary artery outcomeThe Journal of Pediatrics, 2006
- MECHANISM OF THE INHIBITORY EFFECT OF PROTEASE INHIBITOR ON TUMOR NECROSIS FACTOR α PRODUCTION OF MONOCYTESShock, 2001
- Inhibition by dexamethasone of the lipopolysaccharide-induced increase in IL-6 mrna abundance and IL-6 production in human polymorphonuclear leukocytesInternational Journal of Immunopharmacology, 1996
- The production of cytokines by polymorphonuclear neutrophilsImmunology Today, 1995
- Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinasesFEBS Letters, 1988